Profiel
Iftach Seri is currently the Chief Executive Officer & Director at Wavelength Pharmaceuticals Ltd.
and the Director at Remedix Care Ltd.
Actieve functies van Iftach Seri
| Bedrijven | Functie | Begin |
|---|---|---|
Wavelength Pharmaceuticals Ltd.
 Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel. | Algemeen Directeur | 29-11-2017 |
Remedix Care Ltd.
 Remedix Care Ltd. Pharmaceuticals: MajorHealth Technology Part of Super-Pharm (Israel) Ltd., Remedix Care Ltd. is an Israeli company that manufactures drugs for hospitals. The company is based in Ashdod, Israel. The company was founded in 2018. The CEO is Shay Shabat. Remedix Care was acquired by Super-Pharm (Israel) Ltd. from Teva Pharmaceutical Industries Ltd. on April 23, 2021. | Directeur/Bestuurslid | 01-09-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Wavelength Pharmaceuticals Ltd.
Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel. | Health Technology |
Remedix Care Ltd.
Remedix Care Ltd. Pharmaceuticals: MajorHealth Technology Part of Super-Pharm (Israel) Ltd., Remedix Care Ltd. is an Israeli company that manufactures drugs for hospitals. The company is based in Ashdod, Israel. The company was founded in 2018. The CEO is Shay Shabat. Remedix Care was acquired by Super-Pharm (Israel) Ltd. from Teva Pharmaceutical Industries Ltd. on April 23, 2021. | Health Technology |
